Table 2.
Expression of ChREBP, GLUT2 and GLUT1 in different clinical stages
| ChREBP expression in different clinical stages | Negative (0) | Mild (1) | Middle (2) | Strong (3) | Very strong (4) |
|---|---|---|---|---|---|
| Normal | 36% | 36% | 28% | 0% | 0% |
| Adjacent | 46% | 39% | 15% | 0% | 0% |
| I | 50% | 25% | 25% | 0% | 0% |
| II | 31% | 23% | 23% | 8% | 15% |
| III | 30% | 26% | 17% | 9% | 18% |
| GLUT2 expression in different clinical stages | |||||
| Normal | 7% | 14% | 36% | 21% | 22% |
| Adjacent | 15% | 15% | 39% | 31% | 0% |
| I | 100% | 0% | 0% | 0% | 0% |
| II | 54% | 23% | 15% | 8% | 0% |
| III | 61% | 26% | 9% | 4% | 0% |
| GLUT1 expression in different clinical stages | |||||
| Normal | 64% | 36% | 0% | 0% | 0% |
| Adjacent | 69% | 23% | 8% | 0% | 0% |
| I | 25% | 50% | 25% | 0% | 0% |
| II | 8% | 31% | 23% | 38% | 0% |
| III | 9% | 26% | 35% | 26% | 4% |